Cargando…
COVID-19 Susceptibility in Bronchial Asthma
BACKGROUND: Bronchial asthma has not been adequately assessed in coronavirus disease 2019 (COVID-19). Respiratory allergy is associated with significant reductions in the expression of angiotensin-converting enzyme 2 receptor, which is the entry receptor for COVID-19. OBJECTIVE: To observe COVID-19...
Autores principales: | Green, Ilan, Merzon, Eugene, Vinker, Shlomo, Golan-Cohen, Avivit, Magen, Eli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683297/ https://www.ncbi.nlm.nih.gov/pubmed/33242628 http://dx.doi.org/10.1016/j.jaip.2020.11.020 |
Ejemplares similares
-
Selective IgA deficiency and COVID-19
por: Magen, Eli, et al.
Publicado: (2023) -
Predicting COVID-19 severity using major risk factors and received vaccines
por: Israel, Ariel, et al.
Publicado: (2022) -
A Calculator for COVID-19 Severity Prediction Based on Patient Risk Factors and Number of Vaccines Received
por: Israel, Ariel, et al.
Publicado: (2022) -
Clinical and Laboratory Features in the Israeli Population with COVID-19 Infection after Pfizer-BioNTech mRNA Booster Vaccination
por: Israel, Ariel, et al.
Publicado: (2022) -
A higher frequency of physical activity is associated with reduced rates of SARS-CoV-2 infection
por: Green, Ilan, et al.
Publicado: (2022)